Caitong International Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
Caitong International Asset Management's TNDM Position: Q1 2026 in Review
Caitong International Asset Management increased its Tandem Diabetes Care (TNDM) stake by 3,205% in Q1 2026, buying an estimated $300K and bringing the position to 14,245 shares worth $273K. The position accounts for 0.05% of the portfolio, ranked #310.
Caitong International Asset Management first reported a position in TNDM in Q1 2025 and has held it in 5 quarters since. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- Caitong International Asset Management held 14,245 shares of Tandem Diabetes Care worth $273K as of Q1 2026.
- Caitong International Asset Management bought 13,814 Tandem Diabetes Care shares in Q1 2026, an estimated $300K.
- Tandem Diabetes Care made up 0.05% of Caitong International Asset Management's portfolio in Q1 2026, its #310 holding.
- Caitong International Asset Management first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 5 quarters since.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.